Evidence map›Paper›PMID 41251388›Full record

ArticleBritish journal of haematology2025

Base editing platform to investigate pathogenic SAMD9 mutations in paediatric myelodysplastic syndromes.

Gabriele Canciani, Marco Lecis, Giacomo Frati, Valentina D'Agostino, Marta Gelosi, Francesca Del Bufalo, Giuseppe Palumbo, Paolo Palma, Franco Locatelli, Giulia Ceglie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriele CancianiDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.ORCID https://orcid.org/0000-0003-1918-6653
Marco LecisClinical Immunology and Vaccinology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Giacomo FratiDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Valentina D'AgostinoDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Marta GelosiDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Francesca Del BufaloDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Giuseppe PalumboDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Paolo PalmaClinical Immunology and Vaccinology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Franco LocatelliDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.ORCID https://orcid.org/0000-0002-7976-3654
Giulia CeglieDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.ORCID https://orcid.org/0000-0002-4127-6914

Funding

Ministero della Salute, Current Research
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

base editinggene editingpediatric myelodysplastic syndromesSAMD9

Identifiers

PMID41251388
PMCPMC12624196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.